Durinikova E - Search Results

1

Cytotoxic response of 5-fluorouracil-resistant cells to gene- and cell-directed enzyme/prodrug treatment.

Durinikova E, Plava J, Tyciakova S, Skvara P, Vojs Stanova A, Kozovska Z, Kucerova L, Matuskova M. Durinikova E, et al. Cancer Gene Ther. 2018 Dec;25(11-12):285-299. doi: 10.1038/s41417-018-0030-5. Epub 2018 Jun 21. Cancer Gene Ther. 2018. PMID: 29925898

2

ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.

Kozovska Z, Patsalias A, Bajzik V, Durinikova E, Demkova L, Jargasova S, Smolkova B, Plava J, Kucerova L, Matuskova M. Kozovska Z, et al. Among authors: durinikova e. BMC Cancer. 2018 Jun 15;18(1):656. doi: 10.1186/s12885-018-4572-6. BMC Cancer. 2018. PMID: 29902974 Free PMC article.

3

Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.

Matuskova M, Baranovicova L, Kozovska Z, Durinikova E, Pastorakova A, Hunakova L, Waczulikova I, Nencka R, Kucerova L. Matuskova M, et al. Among authors: durinikova e. J Gene Med. 2012 Dec;14(12):776-87. doi: 10.1002/jgm.2684. J Gene Med. 2012. PMID: 23150190

4

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.

Matuskova M, Kozovska Z, Toro L, Durinikova E, Tyciakova S, Cierna Z, Bohovic R, Kucerova L. Matuskova M, et al. Among authors: durinikova e. J Exp Clin Cancer Res. 2015 Apr 9;34(1):33. doi: 10.1186/s13046-015-0149-2. J Exp Clin Cancer Res. 2015. PMID: 25884597 Free PMC article.

5

Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells.

Kucerova L, Durinikova E, Toro L, Cihova M, Miklikova S, Poturnajova M, Kozovska Z, Matuskova M. Kucerova L, et al. Among authors: durinikova e. Cancer Lett. 2017 Nov 1;408:1-9. doi: 10.1016/j.canlet.2017.08.016. Epub 2017 Aug 25. Cancer Lett. 2017. PMID: 28838843 Review.

6

Development of LC-HRMS methods for evaluation of metabolic conversion of 5-fluorocytosine at GDEPT procedure.

Skvara P, Durinikova E, Grabicová K, Mordacikova E, Matuskova M, Vojs Stanova A. Skvara P, et al. Among authors: durinikova e. J Pharm Biomed Anal. 2021 Sep 5;203:114168. doi: 10.1016/j.jpba.2021.114168. Epub 2021 May 24. J Pharm Biomed Anal. 2021. PMID: 34089981

7

Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy.

Ďuriniková E, Kučerová L, Matúšková M. Ďuriniková E, et al. Acta Virol. 2014;58(1):1-13. doi: 10.4149/av_2014_01_3. Acta Virol. 2014. PMID: 24717023 Review.

8

Genetically engineered mesenchymal stromal cells in cancer gene therapy.

Matuskova M, Durinikova E, Altaner C, Kucerova L. Matuskova M, et al. Among authors: durinikova e. Bratisl Lek Listy. 2018;119(4):221-223. doi: 10.4149/BLL_2018_041. Bratisl Lek Listy. 2018. PMID: 29663820 Review.

9

Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells.

Skolekova S, Matuskova M, Bohac M, Toro L, Durinikova E, Tyciakova S, Demkova L, Gursky J, Kucerova L. Skolekova S, et al. Among authors: durinikova e. Cell Commun Signal. 2016 Jan 12;14:4. doi: 10.1186/s12964-016-0127-0. Cell Commun Signal. 2016. PMID: 26759169 Free PMC article.

10

ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.

Durinikova E, Kozovska Z, Poturnajova M, Plava J, Cierna Z, Babelova A, Bohovic R, Schmidtova S, Tomas M, Kucerova L, Matuskova M. Durinikova E, et al. BMC Cancer. 2018 Aug 24;18(1):848. doi: 10.1186/s12885-018-4758-y. BMC Cancer. 2018. PMID: 30143021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters